Fragilidad en la enfermedad renal en etapa terminal: perspectivas actuales

Shankar Prasad Nagaraju; Srinivas Vinayak Shenoy; Ankur Gupta

doi:10.1016/j.nefroe.2021.05.008

Fragilidad en la enfermedad renal en etapa terminal: perspectivas actuales

Translated title of the contribution: Frailty in end stage renal disease: Current perspectives

Shankar Prasad Nagaraju, Srinivas Vinayak Shenoy, Ankur Gupta

Research output: Contribution to journal › Review article › peer-review

Abstract

Frailty is common in end stage renal disease (ESRD) and is a marker of poor outcomes. Its prevalence increases as chronic kidney disease (CKD) progresses. There are different measurement tools available to assess frailty in ESRD. The pathogenesis of frailty in ESRD is multifactorial including uraemia and dialysis related factors. In this current review, we discuss the importance of frailty, its pathogenesis, screening methods, prognostic implications and management strategies in context of ESRD.

Translated title of the contribution	Frailty in end stage renal disease: Current perspectives
Original language	Spanish
Pages (from-to)	531-539
Number of pages	9
Journal	Nefrologia
Volume	42
Issue number	5
DOIs	https://doi.org/10.1016/j.nefroe.2021.05.008
Publication status	Published - 01-09-2022

All Science Journal Classification (ASJC) codes

Nephrology

Access to Document

10.1016/j.nefroe.2021.05.008

Cite this

@article{5561105de2514806b2cd79416d5179f6,

title = "Fragilidad en la enfermedad renal en etapa terminal: perspectivas actuales",

abstract = "Frailty is common in end stage renal disease (ESRD) and is a marker of poor outcomes. Its prevalence increases as chronic kidney disease (CKD) progresses. There are different measurement tools available to assess frailty in ESRD. The pathogenesis of frailty in ESRD is multifactorial including uraemia and dialysis related factors. In this current review, we discuss the importance of frailty, its pathogenesis, screening methods, prognostic implications and management strategies in context of ESRD.",

author = "Nagaraju, {Shankar Prasad} and Shenoy, {Srinivas Vinayak} and Ankur Gupta",

note = "Publisher Copyright: {\textcopyright} 2021 Sociedad Espa{\~n}ola de Nefrolog{\'i}a",

year = "2022",

month = sep,

day = "1",

doi = "10.1016/j.nefroe.2021.05.008",

language = "Spanish",

volume = "42",

pages = "531--539",

journal = "Nefrologia",

issn = "0211-6995",

publisher = "Grupo Aula Medica S.A.",

number = "5",

}

TY - JOUR

T1 - Fragilidad en la enfermedad renal en etapa terminal

T2 - perspectivas actuales

AU - Nagaraju, Shankar Prasad

AU - Shenoy, Srinivas Vinayak

AU - Gupta, Ankur

PY - 2022/9/1

Y1 - 2022/9/1

N2 - Frailty is common in end stage renal disease (ESRD) and is a marker of poor outcomes. Its prevalence increases as chronic kidney disease (CKD) progresses. There are different measurement tools available to assess frailty in ESRD. The pathogenesis of frailty in ESRD is multifactorial including uraemia and dialysis related factors. In this current review, we discuss the importance of frailty, its pathogenesis, screening methods, prognostic implications and management strategies in context of ESRD.

AB - Frailty is common in end stage renal disease (ESRD) and is a marker of poor outcomes. Its prevalence increases as chronic kidney disease (CKD) progresses. There are different measurement tools available to assess frailty in ESRD. The pathogenesis of frailty in ESRD is multifactorial including uraemia and dialysis related factors. In this current review, we discuss the importance of frailty, its pathogenesis, screening methods, prognostic implications and management strategies in context of ESRD.

UR - http://www.scopus.com/inward/record.url?scp=85147825020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85147825020&partnerID=8YFLogxK

U2 - 10.1016/j.nefroe.2021.05.008

DO - 10.1016/j.nefroe.2021.05.008

M3 - Review article

AN - SCOPUS:85147825020

SN - 0211-6995

VL - 42

SP - 531

EP - 539

JO - Nefrologia

JF - Nefrologia

IS - 5

ER -

Fragilidad en la enfermedad renal en etapa terminal: perspectivas actuales

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this